Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POTE ankyrin domain family member I (POTEI) is a protein encoded by the POTEI gene, notable for the presence of ankyrin repeat motifs which are recognized for mediating protein-protein interactions and regulatory functions within the cytoskeleton. POTEI is predicted to participate in protein kinase binding and actin cytoskeleton organization, contributing to cell motility and axonal development. It is found in extracellular exosomes, suggesting potential roles in intercellular communication, but it is not known to be a classical receptor, enzyme, or transport protein and is not currently implicated as a therapeutic target. Paralogs include other POTE family members, some of which have cancer-testis antigen features or are weakly expressed in specific tissues, but distinct druggability or mechanistic information is lacking.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POTE ankyrin domain family member I (POTEI).